Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant in Patients With High Risk Locallized Prostate Cancer
Overview
- Phase
- Not Applicable
- Intervention
- DOCETAXEL
- Conditions
- Prostate Cancer
- Sponsor
- Hanjong Ahn
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- biochemical recurrence rate of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer
- Last Updated
- 14 years ago
Overview
Brief Summary
Effect of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer.
The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and prednisone are effective in the treatment of high risk localized prostate cancer.
Detailed Description
The purpose of this study is to evaluate whether neoajuvant and adjuvant docetaxel and prednisone are effective in the treatment of high risk localized prostate cancer.
Investigators
Hanjong Ahn
Professor
Asan Medical Center
Eligibility Criteria
Inclusion Criteria
- •Prostate Cancer
- •PSA \> 20 OR
- •Clinical Stage \> T2C OR
Exclusion Criteria
- Not provided
Arms & Interventions
contol
control group
Intervention: DOCETAXEL
chemotherapy
neoadjuvant chemotherapy
Intervention: DOCETAXEL
Outcomes
Primary Outcomes
biochemical recurrence rate of Radical Prostatectomy Combined with Neoadjuvant and Adjuvant Chemotherapy in Patients with High Risk Prostate Cancer
Time Frame: 2 Years After RRP